Name | 5-Chloropyrazolo[1,5-a]pyrimidine |
Synonyms | Larotrectinib CPP Impurity WEPRLWNMBTYGGD-UHFFFAOYSA-N 5-Chloropyrazolo[1,5-a]py... 5-CHLOROPYRAZOLO[1,5-A]PYRIMIDINE 5-Chloropyrazolo[1,5-a]pyrimidine Pyrazolo[1,5-a]pyriMidine, 5-chloro- 5-chloro-4,5-dihydropyrazolo[1,5-a]pyrimidine |
CAS | 29274-24-6 |
InChI | InChI=1/C6H4ClN3/c7-5-2-4-10-6(9-5)1-3-8-10/h1-4H |
Molecular Formula | C6H4ClN3 |
Molar Mass | 153.57 |
Density | 1.51±0.1 g/cm3(Predicted) |
pKa | -0.49±0.30(Predicted) |
Storage Condition | under inert gas (nitrogen or Argon) at 2-8°C |
Refractive Index | 1.713 |
UN IDs | UN2811 |
Hazard Class | IRRITANT |
Introduction | 5-chlorpyrazolo [1,5-a] pyrimidine molecule has two important active units of pyrazole and pyrimidine at the same time. Therefore, these compounds often have good biological activity and have been concerned by pharmaceutical chemists for a long time. Pyrazolo [1,5-a] pyrimidine derivatives have good biological activity and can be used as anti-schistosomiasis agents, anti-tumor drugs, and drugs for the treatment of sleep disorders. |
Synthesis method | Using 3-aminopyrazole and ethyl propionate as starting materials, pyrazolo [1,5-a] pyrimidine -5(4H)-one was synthesized, and then the target compound 5-chloropyrazolo [1,5-a] pyrimidine was prepared by chlorination. The synthesis reaction formula is as follows: |